2023 has come roaring in, and we have so much to share with you in this newsletter! Read on for all the kidney cancer updates:

• Town Hall event recap (and save the date for our next event)
• The latest research news from ASCO #GU23
• Spring Kidney Cancer Advocacy Days
• March Kidney Cancer Awareness Month
• Community Spotlight
• KCRS23: Call for Abstracts

Thank you for being part of our community!

We held our popular research Town Hall webinar in January. Renowned clinical kidney cancer researchers Dr. Rana McKay (UC San Diego) and Dr. Hans Hammers (UT Southwestern) shared a retrospective of 2022 breakthroughs, along with a look forward at what we can expect in 2023.

Their presentations were followed by a lively Q & A session with patients from all over the country. If you missed the live event, you can watch the video and see all the resources shared on our website:

SAVE THE DATE: Our next Town Hall, titled “Making the Most of More Time: Stories of Survivorship,” will be on April 25, 2023.

KidneyCAN President Bryan Lewis connected with former NCI Director Ned Sharpless at the ASCO GU conference held in mid-February.

Patient-Friendly Trial Info:

ASCO GU Conference News

The 2023 ASCO Genitourinary (GU) Cancers Symposium is an annual conference where researchers present new, innovative findings in the study, diagnosis, and treatment of GU malignancies.

Our friends at the International Kidney Cancer Coalition have put together a patient-friendly breakdown of the news presented at this year's conference. Be sure to check it out:

Research Funding Requires Advocacy!

Join Us for Spring Kidney Cancer Advocacy Days

KidneyCAN will be on the ground in Washington, D.C. (and virtually all over the country) for our Spring Kidney Cancer Advocacy Days on March 13-14!

We still need folks willing to share their story and ask Congress to fund kidney cancer research. Please plan to join us, and invite your family and friends!

Let's #AccelerateCures in March:

Kidney Cancer Awareness Month

March is Kidney Cancer Awareness Month, and KidneyCAN wants to remind you to stay tuned for all of the inspiring resources, educational information, and stories we will be sharing on our social media and website throughout the month.

Join us in raising awareness about kidney cancer and supporting patients and families impacted by this disease! Kick off the month with a donation:

For this month’s Community Spotlight, we are sharing the story of our friend Chuck, who was diagnosed with stage IV kidney cancer in 2015.

Since his diagnosis, Chuck has become an ambassador for kidney cancer patients, speaking to doctors and researchers about patients' experiences. He also advocates for research funding. In this feature, Chuck reflects on time and hope, as well as the critical need for continued research.

“A cancer diagnosis changes your life. Your life is never the same, but with time comes hope that we will someday find a cure. And hope that, for patients like me, the next clinical trial is the one that keeps the cancer under control with fewer side effects and a better quality of life.

Sometimes, time and hope are all we have."

Punch Your Ticket to #KCRS23 in Boston:

Submit Your Original Research Abstract

Join the most renowned researchers in the world at the 2023 Kidney Cancer Research Summit! We're now accepting abstract submissions for original research in kidney cancer.

If your abstract is accepted for presentation, you can attend KCRS23 fully sponsored! Be a part of this exciting event and contribute to the acceleration of cures.

Submit your work today!

Are you following KidneyCAN online? Tag @KidneyCAN

in your #kidneycancer posts!

KidneyCAN has launched an online shop for our friends to support our work and raise awareness with KidneyCAN apparel! Wear your KidneyCAN spirit with pride, and know that every penny we receive from your purchase goes toward accelerating cures for kidney cancer!

KidneyCAN is a registered 501(c)(3) nonprofit and does not receive any funding through the Congressionally Directed Medical Research Programs (CDMRP) or KCRP (Kidney Cancer Research Program). KidneyCAN's work is funded entirely through donations and contributions.